Neuroprotection by Exendin-4 Is GLP-1 Receptor Specific but DA D3 Receptor Dependent, Causing Altered BrdU Incorporation in Subventricular Zone and Substantia Nigra
Quantified histograms of DAB-stained cell counts from 6 sections from each of the brains in the treatment group () were used for analysis. DAB cell counts along the wall of the SVZ (a) or SN (b) were carried out manually. Results were analyzed using one-way ANOVA (SVZ ; SN ) and a post hoc Bonferroni test to compare relevant treatment groups. * indicates significant difference compared to sham and 6-OHDA + EX-4. ** indicates significant difference compared to 6-OHDA and EX-4 treatment.